Benefits
Less Muscle Soreness After Exercise, in People Who Already Train
A meta-analysis of 10 randomized trials (9 pooled) found BCAAs reduced delayed onset muscle soreness 24 to 72 hours after one bout of exercise. The authors limited that to trained people, doses up to 255 mg/kg a day (about 18 g at 70 kg) and mild to moderate muscle damage, advised against giving BCAAs only after exercise, and could not say whether they help untrained people. Soreness was the only outcome.
Muscle protein synthesis from BCAAs alone
Leucine switches on the muscle growth signal, but new muscle protein also needs the other essential amino acids. A review of the human research found no study measuring muscle protein synthesis after oral BCAAs alone; in two intravenous studies BCAAs lowered both synthesis and breakdown. Complete protein or a full essential amino acid mix supplies all the building blocks.
Exercise fatigue and the central fatigue idea
The idea is that BCAAs compete with tryptophan for entry into the brain and so lower serotonin, which is linked to tiredness during long exercise. No study cited on this page tested fatigue or endurance, so training longer or harder with BCAAs is unproven here.
Mechanism of action
Muscle Protein Synthesis (MPS)
Leucine is the primary driver, activating the mTOR (mammalian target of rapamycin) signaling pathway in muscle cells. mTOR stimulates the translation of proteins, promoting muscle growth and repair. This is critical post-exercise when muscle fibers need rebuilding. Leucine increases the phosphorylation of proteins like p70S6 kinase, enhancing ribosomal activity and protein synthesis. A mechanism is not an outcome: no study cited on this page measured muscle size, and any complete protein containing leucine activates the same pathway.
Reduced Muscle Breakdown
BCAAs serve as an energy source during prolonged exercise or calorie restriction, reducing the need for the body to break down muscle tissue for energy. They are metabolized directly in skeletal muscle (unlike other amino acids, which are primarily processed in the liver), providing quick energy and sparing muscle protein. BCAAs also raise insulin somewhat, which is thought to slow protein breakdown. This is metabolic reasoning from laboratory work; no trial cited on this page measured muscle loss or preservation in people.
Delayed Exercise Fatigue
During prolonged exercise, BCAAs compete with tryptophan for transport across the blood-brain barrier. Lower BCAA levels (due to muscle uptake) allow more tryptophan to enter the brain, increasing serotonin production, which contributes to fatigue. Supplementing BCAAs maintains higher plasma BCAA levels, reducing tryptophan uptake and delaying fatigue. This central fatigue idea remains a hypothesis. Human results have been inconsistent, and no reference cited on this page tested endurance or fatigue.
Energy Production
BCAAs are oxidized in skeletal muscle via enzymes like branched-chain aminotransferase (BCAT) and branched-chain alpha-ketoacid dehydrogenase (BCKDH). This produces energy (ATP) and intermediates such as glutamine. What that means for recovery or immune function in real training was not tested in any study cited on this page.
Clinical trials
Systematic review and meta-analysis of 10 randomized trials, 9 of them pooled, of BCAA supplementation and delayed onset muscle soreness in healthy people after a single bout of muscle-damaging exercise. (Weber et al. 2021, Amino Acids)
Healthy people doing one bout of muscle-damaging exercise, pooled across the included randomized trials; the authors' conclusions applied to trained subjects.
Seven of the ten trials found less soreness 24 to 72 hours after exercise. The authors judged BCAAs useful in trained subjects, at up to 255 mg/kg a day (about 18 g at 70 kg), in mild to moderate muscle damage, and said they should not be given only after the exercise. Variability between studies left untrained people, higher doses, and acute versus multi-day dosing unresolved. Soreness was the only outcome reviewed.